Beijing Bio-targeting Therapeutics Technology Co., Ltd

This early-stage study is testing a new treatment for people with aggressive brain tumors (high-grade glioma) that have come back or gotten worse after standard therapy. Doctors inject a specially engineered virus directly into the brain tumor. The virus is designed to infect and…

This is a first-in-human safety study testing a new cancer treatment called BioTTT001. It is a modified virus designed to be injected directly into tumors to kill cancer cells and stimulate the immune system. The study will enroll 12 adults with advanced solid tumors (like head/n…

This early-stage study aimed to test the safety and find the right dose of a new virus-based injection (BioTTT001) when given alongside standard pre-surgery treatment for locally advanced breast cancer. The trial planned to enroll women with non-metastatic breast cancer to receiv…